Novavax Inc (NVAX)
13.61
-0.81
(-5.62%)
USD |
NASDAQ |
Oct 04, 16:00
13.66
+0.05
(+0.37%)
Pre-Market: 20:00
Novavax Shareholders Equity (Annual): -716.93M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -716.93M |
| December 31, 2022 | -634.08M |
| December 31, 2021 | -351.67M |
| December 31, 2020 | 627.21M |
| December 31, 2019 | -186.02M |
| December 31, 2018 | -167.94M |
| December 31, 2017 | -101.73M |
| December 31, 2016 | -5.546M |
| December 31, 2015 | 292.67M |
| December 31, 2014 | 229.62M |
| December 31, 2013 | 203.23M |
| December 31, 2012 | 80.24M |
| December 31, 2011 | 53.85M |
| December 31, 2010 | 59.05M |
| Date | Value |
|---|---|
| December 31, 2009 | 69.95M |
| December 31, 2008 | 45.49M |
| December 31, 2007 | 63.06M |
| December 31, 2006 | 94.00M |
| December 31, 2005 | 49.65M |
| December 31, 2004 | 33.28M |
| December 31, 2003 | 35.94M |
| December 31, 2002 | 8.073M |
| December 31, 2001 | 27.49M |
| December 31, 2000 | 31.82M |
| December 31, 1999 | 2.80M |
| December 31, 1998 | 3.00M |
| December 31, 1997 | 6.50M |
| December 31, 1996 | 5.10M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-716.93M
Minimum
2023
627.21M
Maximum
2020
-252.30M
Average
-351.67M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Pfizer Inc | 89.01B |
| Moderna Inc | 13.85B |
| BioCryst Pharmaceuticals Inc | -455.53M |
| Boston Scientific Corp | 19.28B |
| Eli Lilly and Co | 10.77B |